Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Analysis of breast cancer cells
PubMed Full text in PMC Similar studies
PRO-seq analysis of estradiol, OP-1250, fulvestrant and 4OH-tamoxifen treatments at multiple timepoints in breast cancer cells
PubMed Full text in PMC Similar studies Analyze with GEO2R
Evaluating hormone responses in Esr1-wildtype and mutant mammary luminal cells [RNA-seq]
PubMed Similar studies SRA Run Selector
Evaluating ER-alpha and PR interactions with chromatin in Esr1-wildtype and mutant mammary luminal cells
Inhibition of CDK8 Mediator Kinase Suppresses Estrogen Receptor Signaling and Growth of Estrogen Receptor Positive Breast Cancer
Targeting ESR1 mutation-induced transcriptional addiction with BET inhibition
Expression data from MCF7 wt and MCF7/HER2-18 xenografts
Expression data from MCF7 wt xenografts
Expression data from MCF7/HER2-18 xenografts
Genome-wide copy number profiling of MCF-7 and fulvestrant-resistant MCF-7/FR cells by SNP microarray.
Fulvestrant withdrawal from fulvestrant-resistant MCF-7/FR cells
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative [cohort 3273]
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative [superseries]
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative [cohort 405]
Gene expression profiling of breast cancer cells with knockdown of PTEN
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq]
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [ChIP-Seq]
PubMed Full text in PMC Similar studies SRA Run Selector
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts
PubMed Similar studies Analyze with GEO2RSRA Run Selector
Transcriptome Analysis Reveals a Role for Myc in Constitutive and Antiestrogen-resistant Proliferation of Breast Cancer Cells Expressing ERαY537S and ERαD538G Mutations
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on